{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:49:13Z","timestamp":1787161753113,"version":"build-2736575974"},"reference-count":49,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["VR4-172738"],"award-info":[{"award-number":["VR4-172738"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2022,1,7]]},"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To summarise specific adverse effects of remdesivir, hydroxychloroquine and lopinavir\/ritonavir in patients with COVID-19.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched 32 databases through 27 October 2020. We included randomised trials comparing any of the drugs of interest to placebo or standard care, or against each other. We conducted fixed-effects pairwise meta-analysis and assessed the certainty of evidence using the grading of recommendations assessment, development and evaluation approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We included 16 randomised trials which enrolled 8152 patients. For most interventions and outcomes the certainty of the evidence was very low to low except for gastrointestinal adverse effects from hydroxychloroquine, which was moderate certainty. Compared with standard care or placebo, low certainty evidence suggests that remdesivir may not have an important effect on acute kidney injury (risk difference (RD) 8 fewer per 1000, 95% CI 27 fewer to 21 more) or cognitive dysfunction\/delirium (RD 3 more per 1000, 95% CI 12 fewer to 19 more). Low certainty evidence suggests that hydroxychloroquine may increase the risk of cardiac toxicity (RD 10 more per 1000, 95% CI 0 more to 30 more) and cognitive dysfunction\/delirium (RD 33 more per 1000, 95% CI 18 fewer to 84 more), whereas moderate certainty evidence suggests hydroxychloroquine probably increases the risk of diarrhoea (RD 106 more per 1000, 95% CI 48 more to 175 more) and nausea and\/or vomiting (RD 62 more per 1000, 95% CI 23 more to 110 more) compared with standard care or placebo. Low certainty evidence suggests lopinavir\/ritonavir may increase the risk of diarrhoea (RD 168 more per 1000, 95% CI 58 more to 330 more) and nausea and\/or vomiting (RD 160 more per 1000, 95% CI 100 more to 210 more) compared with standard care or placebo.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Hydroxychloroquine probably increases the risk of diarrhoea and nausea and\/or vomiting and may increase the risk of cardiac toxicity and cognitive dysfunction\/delirium. Lopinavir\/ritonavir may increase the risk of diarrhoea and nausea and\/or vomiting. Remdesivir may have no important effect on risk of acute kidney injury or cognitive dysfunction\/delirium. These findings provide important information to support the development of evidence-based management strategies for patients with COVID-19.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2020-048502","type":"journal-article","created":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T11:07:03Z","timestamp":1646219223000},"page":"e048502","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":49,"title":["Adverse effects of remdesivir, hydroxychloroquine and lopinavir\/ritonavir when used for COVID-19: systematic review and meta-analysis of randomised trials"],"prefix":"10.1136","volume":"12","clinical-trial-number":[{"clinical-trial-number":"nct04280705","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04322123","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04261517","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04384380","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04381936","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04252885","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04316377","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04308668","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04369742","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04257656","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9053-4396","authenticated-orcid":false,"given":"Ariel","family":"Izcovich","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Hospital Alem\u00e1n de Buenos Aires, Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3725-3031","authenticated-orcid":false,"given":"Reed Alexander","family":"Siemieniuk","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact (HEI), McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6743-3538","authenticated-orcid":false,"given":"Jessica Julia","family":"Bartoszko","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact (HEI), McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3555-1107","authenticated-orcid":false,"given":"Long","family":"Ge","sequence":"additional","affiliation":[{"name":"Evidence Based Social Science Research Center, School of Public Health, Lanzhou University, Lanzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4287-0541","authenticated-orcid":false,"given":"Dena","family":"Zeraatkar","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact (HEI), McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Kum","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact (HEI), McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anila","family":"Qasim","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact (HEI), McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5567-7065","authenticated-orcid":false,"given":"Assem M","family":"Khamis","sequence":"additional","affiliation":[{"name":"Hull York Medical School, University of Hull, York, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bram","family":"Rochwerg","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact (HEI), McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6182-9969","authenticated-orcid":false,"given":"Thomas","family":"Agoritsas","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact (HEI), McMaster University, Hamilton, Ontario, Canada"},{"name":"Division of General Internal Medicine & Division of Epidemiology, University Hospitals of Geneva, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek K","family":"Chu","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact (HEI), McMaster University, Hamilton, Ontario, Canada"},{"name":"Department of Medicine, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley L","family":"McLeod","sequence":"additional","affiliation":[{"name":"Schwartz\/Reisman Emergency Medicine Institute, Sinai Health System, Toronto, Ontario, Canada"},{"name":"Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem A","family":"Mustafa","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact (HEI), McMaster University, Hamilton, Ontario, Canada"},{"name":"Department of Medicine, University of Kansas Medical Center, Kansas City, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Vandvik","sequence":"additional","affiliation":[{"name":"MAGIC Evidence Ecosystem Foundation, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"Brignardello-Petersen","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact (HEI), McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,3,2]]},"reference":[{"key":"2025121409250092000_12.3.e048502.1","unstructured":"John Hopkins University . Coronavirus resource center, 2020. Available: https:\/\/coronavirus.jhu.edu\/map.html [Accessed Nov 2020]."},{"key":"2025121409250092000_12.3.e048502.2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m2980"},{"key":"2025121409250092000_12.3.e048502.3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i5191"},{"key":"2025121409250092000_12.3.e048502.4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m2924"},{"key":"2025121409250092000_12.3.e048502.5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3379"},{"key":"2025121409250092000_12.3.e048502.6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2535"},{"key":"2025121409250092000_12.3.e048502.7","unstructured":"World Health Organization . Global research on coronavirus disease (COVID-19). Available: https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/global-research-on-novel-coronavirus-2019-ncov [Accessed Oct 2020]."},{"key":"2025121409250092000_12.3.e048502.8","unstructured":"The Stephen B . Thacker CDC library. COVID-19 research articles Downloadable database: U.S. centers for disease control and prevention (CDC), 2020. Available: https:\/\/www.cdc.gov\/library\/researchguides\/2019novelcoronavirus\/researcharticles.html [Accessed Oct 2020]."},{"key":"2025121409250092000_12.3.e048502.9","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/jrsm.1287","article-title":"Machine learning for identifying randomized controlled trials: an evaluation and practitioner's guide","volume":"9","author":"Marshall","year":"2018","journal-title":"Res Synth Methods"},{"key":"2025121409250092000_12.3.e048502.10","unstructured":"Epistemonikos Foundation . Living evidence repository for COVID-19. Available: https:\/\/app.iloveevidence.com\/loves\/5e6fdb9669c00e4ac072701d [Accessed Oct 2020]."},{"key":"2025121409250092000_12.3.e048502.11","unstructured":"Norwegian Institute of Public Health . NIPH systematic and living map on COVID-19 evidence, 2020. Available: https:\/\/www.nornesk.no\/forskningskart\/NIPH_mainMap.html [Accessed Oct 2020]."},{"key":"2025121409250092000_12.3.e048502.12","unstructured":"Veritas Health Innovation . COVIDence systematic review software [program. Melbourne, Australia."},{"key":"2025121409250092000_12.3.e048502.13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3379"},{"key":"2025121409250092000_12.3.e048502.14","unstructured":"World Health Organization . Therapeutics and COVID-19: living guideline. Available: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/337876\/WHO-2019-nCoV-therapeutics-2020.1-eng.pdf"},{"key":"2025121409250092000_12.3.e048502.15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898"},{"key":"2025121409250092000_12.3.e048502.16","doi-asserted-by":"publisher","DOI":"10.1136\/ebmental-2019-300117"},{"key":"2025121409250092000_12.3.e048502.17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.328.7454.1490"},{"key":"2025121409250092000_12.3.e048502.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2017.05.006"},{"key":"2025121409250092000_12.3.e048502.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2019.10.014"},{"key":"2025121409250092000_12.3.e048502.20","first-page":"1","article-title":"Bayesian random-effects meta-analysis using the bayesmeta R package","volume":"93","author":"Rover","year":"2017","journal-title":"Journal of Statistical Software"},{"key":"2025121409250092000_12.3.e048502.21","doi-asserted-by":"publisher","DOI":"10.1002\/sim.6381"},{"key":"2025121409250092000_12.3.e048502.22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2007764"},{"key":"2025121409250092000_12.3.e048502.23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001282"},{"key":"2025121409250092000_12.3.e048502.24","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1056\/NEJMoa2019014","article-title":"Coalition Covid-19 Brazil I Investigators. hydroxychloroquine with or without azithromycin in mild-to-moderate Covid-19","volume":"383","author":"Cavalcanti","year":"2020","journal-title":"N Engl J Med"},{"key":"2025121409250092000_12.3.e048502.25","unstructured":"Chen Z , Hu J , Zhang Z . Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial. medRxiv."},{"key":"2025121409250092000_12.3.e048502.26","doi-asserted-by":"publisher","DOI":"10.1101\/2020.06.17.20133579"},{"key":"2025121409250092000_12.3.e048502.27","unstructured":"Chen L , Z-y Z , J-g F . Efficacy and safety of chloroquine or hydroxychloroquine in moderate type of COVID-19: a prospective open-label randomized controlled study. medRxiv."},{"key":"2025121409250092000_12.3.e048502.28","unstructured":"Chen C-P , Lin Y-C , Chen T-C . A multicenter, randomized, open-label, controlled trial to evaluate the efficacy and tolerability of hydroxychloroquine and a retrospective study in adult patients with mild to moderate coronavirus disease 2019 (COVID-19). medRxiv(Published online first: 10 July 2020)."},{"key":"2025121409250092000_12.3.e048502.29","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1056\/NEJMoa2022926","article-title":"Effect of hydroxychloroquine in hospitalized patients with Covid-19","volume":"383","author":"Horby","year":"2020","journal-title":"N Engl J Med"},{"key":"2025121409250092000_12.3.e048502.30","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.01071"},{"key":"2025121409250092000_12.3.e048502.31","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.medj.2020.04.001","article-title":"Efficacy and safety of Lopinavir\/Ritonavir or arbidol in adult patients with Mild\/Moderate COVID-19: an exploratory randomized controlled trial","volume":"1","author":"Li","year":"2020","journal-title":"Med"},{"key":"2025121409250092000_12.3.e048502.32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19056-6"},{"key":"2025121409250092000_12.3.e048502.33","doi-asserted-by":"publisher","DOI":"10.7326\/M20-4207"},{"key":"2025121409250092000_12.3.e048502.34","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1849"},{"key":"2025121409250092000_12.3.e048502.35","doi-asserted-by":"crossref","first-page":"ofaa446","DOI":"10.1093\/ofid\/ofaa446","article-title":"Treating COVID-19 with hydroxychloroquine (teach): a multicenter, double-blind randomized controlled trial in hospitalized patients","volume":"7","author":"Ulrich","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"2025121409250092000_12.3.e048502.36","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31022-9"},{"key":"2025121409250092000_12.3.e048502.37","unstructured":"Zheng F , Zhou Y , Zhou Z . A novel protein drug, Novaferon as the potential antiviral drug for COVID-19. medRxiv."},{"key":"2025121409250092000_12.3.e048502.38","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2020.101812","article-title":"Hydroxychloroquine safety: a meta-analysis of randomized controlled trials","volume":"36","author":"Eljaaly","year":"2020","journal-title":"Travel Med Infect Dis"},{"key":"2025121409250092000_12.3.e048502.39","first-page":"30","article-title":"Risk factors for gastrointestinal adverse events in HIV treated and untreated patients","volume":"11","author":"Hill","year":"2009","journal-title":"AIDS Rev"},{"key":"2025121409250092000_12.3.e048502.40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002127"},{"key":"2025121409250092000_12.3.e048502.41","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4103\/ijp.IJP_627_20","article-title":"Safety and efficacy of lopinavir\/ritonavir combination in COVID-19: a systematic review, meta-analysis, and meta-regression analysis","volume":"52","author":"Bhattacharyya","year":"2020","journal-title":"Indian J Pharmacol"},{"key":"2025121409250092000_12.3.e048502.42","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.200647"},{"key":"2025121409250092000_12.3.e048502.43","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3389\/fmed.2020.00482","article-title":"Efficacy and safety of anti-malarial drugs (chloroquine and Hydroxy-Chloroquine) in treatment of COVID-19 infection: a systematic review and meta-analysis","volume":"7","author":"Das","year":"2020","journal-title":"Front Med"},{"key":"2025121409250092000_12.3.e048502.44","doi-asserted-by":"crossref","first-page":"287","DOI":"10.7326\/M20-2496","article-title":"Hydroxychloroquine or chloroquine for treatment or prophylaxis of COVID-19: a living systematic review","volume":"173","author":"Hernandez","year":"2020","journal-title":"Ann Intern Med"},{"key":"2025121409250092000_12.3.e048502.45","doi-asserted-by":"crossref","unstructured":"Shrestha DB , Budhathoki P , Khadka S . Hydroxychloroquine with or without macrolide and standard of care versus standard of care alone for COVID-19 cases: a systematic review and meta-analysis. Research Square 2020.","DOI":"10.21203\/rs.3.rs-39092\/v1"},{"key":"2025121409250092000_12.3.e048502.46","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2020.05.008"},{"key":"2025121409250092000_12.3.e048502.47","doi-asserted-by":"crossref","unstructured":"Kim MS , Ho An M , Jun Kim W , et al . Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: a systematic review and network meta-analysis of Confounder-Adjusted 36813 hospitalized patients. SSRN Journal.doi:10.2139\/ssrn.3619770","DOI":"10.2139\/ssrn.3619770"},{"key":"2025121409250092000_12.3.e048502.48","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/JCMA.0000000000000425","article-title":"Systematic review and meta-analysis of the effectiveness and safety of hydroxychloroquine in treating COVID-19 patients","volume":"84","author":"Yang","year":"2021","journal-title":"J Chin Med Assoc"},{"key":"2025121409250092000_12.3.e048502.49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0243705","article-title":"Efficacy and harms of remdesivir for the treatment of COVID-19: a systematic review and meta-analysis","volume":"15","author":"Piscoya","year":"2020","journal-title":"PLoS One"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2020-048502","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T17:25:12Z","timestamp":1765733112000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2020-048502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":49,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3,2]]},"published-print":{"date-parts":[[2022,3]]}},"alternative-id":["10.1136\/bmjopen-2020-048502"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2020-048502","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.11.16.20232876","asserted-by":"object"}]},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3]]}}}